Research Article

LED-Driven Photodynamic Therapy for Antimicrobial Application

Volume: 9 Number: 4 July 15, 2026
EN TR

LED-Driven Photodynamic Therapy for Antimicrobial Application

Abstract

The improper and widespread use of antibiotics has escalated antimicrobial resistance (AMR) into a global challenge. AMR, the capacity of microorganisms to withstand potent antibiotics via intrinsic or genetic adaptations, creates substantial obstacles in clinical practice. Microbial colonization on implant surfaces necessitates the development of adaptable, biocompatible, and “smart” materials for the tissue–biomaterial interface. In this study, a light-activated self-sterilizing alginate-based film was engineered via sol–gel process by incorporating a bis-iodo-substituted Boron-dipyrromethene (I₂-BODIPY) photosensitizer known for its high singlet-oxygen (¹O₂) quantum yield, stability, and photodynamic efficiency. The system was evaluated in terms of both its cytotoxicity toward mammalian cells and its antimicrobial activity against bacteria. In planktonic bacterial assays, gram positive Staphylococcus aureus (S. aureus) showed a rapid and pronounced loss of viability at 0.106–5 µM under 5 mW cm⁻² green LED irradiation. In contrast, Escherichia coli (E. coli) required higher treatment intensities, > 3log reductions observed under 10–15 mW cm⁻² irradiation at concentrations ≥5 µM. As for the film material, alginate was selected owing to its relevance in microbial growth settings and suitability for tissue engineering applications. Overall, the film was evaluated in vitro under representative conditions, resulted with >3-log reduction for S. aureus. These findings indicate that the I₂-BODIPY–integrated alginate film, via ROS-mediated photodynamic action, holds promise as a photosensitive, light-activated self-sterilizing platform for preventing implant-associated microbial infections.

Keywords

Supporting Institution

Izmir Democracy University

Project Number

HIZDEP_MHF/2402

Ethical Statement

Ethics committee approval was not required for this study because of there was no study on animals or humans.

Thanks

This research was funded by Izmir Democracy University, grant number. HIZDEP_MHF/2402. The author gratefully thank Dr. Burcin Karabey, Dr. Muhammed Ucuncu and Yunus Emre Ersoy for their support.

References

  1. Abourehab, M. A. S., Rajendran, R. R., Singh, A., Pramanik, S., Shrivastav, P., Ansari, M. J., Manne, R., Amaral, L. S., & Deepak, A. (2022). Alginate as a Promising Biopolymer in Drug Delivery and Wound Healing: A Review of the State-of-the-Art. International journal of molecular sciences, 23(16), 9035. Bispo, M., Santos, S. B., Melo, L. D. R., Azeredo, J., & van Dijl, J. M. (2022). Targeted Antimicrobial Photodynamic Therapy of Biofilm-Embedded and Intracellular Staphylococci with a Phage Endolysin's Cell Binding Domain. Microbiology spectrum, 10(1), e0146621.
  2. Dai, T., Huang, Y. Y., & Hamblin, M. R. (2009). Photodynamic therapy for localized infections—state of the art. Photodiagnosis and Photodynamic Therapy, 6(3–4), 170–188.
  3. Dartar, S., Ucuncu, M., Karakus, E., Hou, Y., Zhao, J., & Emrullahoglu, M. (2021). BODIPY–vinyl dibromides as triplet sensitisers for photodynamic therapy and triplet–triplet annihilation upconversion. Chemical Communications, 57(49), 6039–6042.
  4. Das, S., Dey, S., Patra, S., Bera, A., Ghosh, T., Prasad, B., Sayala, K. D., Maji, K., Bedi, A., & Debnath, S. (2023). BODIPY-based molecules for biomedical applications. Biomolecules, 13(12),1723.
  5. Flemming, H. C., & Wingender, J. (2010). The biofilm matrix. Nature Reviews Microbiology, 8(9), 623–633.
  6. Gayathri, T., Karnewar, S., Kotamraju, S., & Singh, S. P. (2018). High affinity neutral Bodipy fluorophores for mitochondrial tracking. ACS Medicinal Chemistry Letters, 9(7), 618–622.
  7. Hamblin, M. R. (2016). Antimicrobial photodynamic inactivation: A bright new technique to kill resistant microbes. Current Opinion in Microbiology, 33, 67–73.
  8. Hu, X., Huang, Y. Y., Wang, Y., Wang, X., & Hamblin, M. R. (2018). Antimicrobial photodynamic therapy to control clinically relevant biofilm infections. Frontiers in Microbiology, 9, 1299.

Details

Primary Language

English

Subjects

Biomedical Sciences and Technology, Biomedical Therapy

Journal Section

Research Article

Publication Date

July 15, 2026

Submission Date

June 10, 2026

Acceptance Date

July 9, 2026

Published in Issue

Year 2026 Volume: 9 Number: 4

APA
Saygılı, E. (2026). LED-Driven Photodynamic Therapy for Antimicrobial Application. Black Sea Journal of Engineering and Science, 9(4), 1998-2006. https://doi.org/10.34248/bsengineering.1968370
AMA
1.Saygılı E. LED-Driven Photodynamic Therapy for Antimicrobial Application. BSJ Eng. Sci. 2026;9(4):1998-2006. doi:10.34248/bsengineering.1968370
Chicago
Saygılı, Ecem. 2026. “LED-Driven Photodynamic Therapy for Antimicrobial Application”. Black Sea Journal of Engineering and Science 9 (4): 1998-2006. https://doi.org/10.34248/bsengineering.1968370.
EndNote
Saygılı E (July 1, 2026) LED-Driven Photodynamic Therapy for Antimicrobial Application. Black Sea Journal of Engineering and Science 9 4 1998–2006.
IEEE
[1]E. Saygılı, “LED-Driven Photodynamic Therapy for Antimicrobial Application”, BSJ Eng. Sci., vol. 9, no. 4, pp. 1998–2006, July 2026, doi: 10.34248/bsengineering.1968370.
ISNAD
Saygılı, Ecem. “LED-Driven Photodynamic Therapy for Antimicrobial Application”. Black Sea Journal of Engineering and Science 9/4 (July 1, 2026): 1998-2006. https://doi.org/10.34248/bsengineering.1968370.
JAMA
1.Saygılı E. LED-Driven Photodynamic Therapy for Antimicrobial Application. BSJ Eng. Sci. 2026;9:1998–2006.
MLA
Saygılı, Ecem. “LED-Driven Photodynamic Therapy for Antimicrobial Application”. Black Sea Journal of Engineering and Science, vol. 9, no. 4, July 2026, pp. 1998-06, doi:10.34248/bsengineering.1968370.
Vancouver
1.Ecem Saygılı. LED-Driven Photodynamic Therapy for Antimicrobial Application. BSJ Eng. Sci. 2026 Jul. 1;9(4):1998-2006. doi:10.34248/bsengineering.1968370

                            24890